|
Viromed Medical AG / Key word(s): Takeover/Mergers & Acquisitions Viromed Medical AG completes acquisition of pharmedix GmbH 20-Dec-2024 / 14:05 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group. The issuer is solely responsible for the content of this announcement. Viromed Medical AG completes acquisition of pharmedix GmbH
Pinneberg, 20 December 2024 – Today, Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) completed the announced acquisition of pharmedix GmbH by notarized purchase agreement. The acquisition is effective as of 1 January 2025. Following the successful acquisition of pharmedix GmbH, Viromed Medical AG now expects consolidated revenues in the low double-digit million euro range for the 2025 financial year, a significant increase over the previous year. Contact Viromed Medical AG Uwe Perbandt End of Inside Information 20-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
New study offers clues on how to future-proof covid-19 vaccines
New research examining how frequently our bodies produce broadly neutralizing antibodies (bnAbs) capable of thwarting a range of SARS-CoV-2 variants offers clues on the strategy
June 27, 2023